Foto del docente

Valentina Ambrosini

Associate Professor

Department of Experimental, Diagnostic and Specialty Medicine - DIMES

Academic discipline: MED/36 Imaging and Radiotherapy

Publications

Zanoni L.; Argalia G.; Fortunati E.; Malizia C.; Allegri V.; Calabro D.; Civollani S.; Campana D.; Fanti S.; Ambrosini V., Can Q.Clear reconstruction be used to improve [68 Ga]Ga-DOTANOC PET/CT image quality in overweight NEN patients?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2022, 49, pp. 1607 - 1612 [Scientific article]

Fortunati E.; Argalia G.; Zanoni L.; Fanti S.; Ambrosini V., New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms, «CURRENT TREATMENT OPTIONS IN ONCOLOGY», 2022, 23, pp. 703-720 - 720 [Scientific article]Open Access

Ambrosini, Valentina; Zanoni, Lucia; Filice, Angelina; Lamberti, Giuseppe; Argalia, Giulia; Fortunati, Emilia; Campana, Davide; Versari, Annibale; Fanti, Stefano, Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors, «CANCERS», 2022, 14, pp. 1055 - 1083 [Scientific article]

Alessandro Bevilacqua, Diletta Calabrò, Silvia Malavasi, Claudio Ricci, Riccardo Casadei, Davide Campana, Serena Baiocco, Stefano Fanti, Valentina Ambrosini, A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours, «DIAGNOSTICS», 2021, 11, Article number: 870 , pp. 1 - 16 [Scientific article]

Dall'Olio FG, Calabrò D, Conci N, Argalia G, Marchese PV, Fabbri F, Fragomeno B, Ricci D, Fanti S, Ambrosini V, Ardizzoni A., Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab., «EUROPEAN JOURNAL OF CANCER», 2021, 150, pp. 99 - 107 [Scientific article]

Pantaleo M.A.; Mandruzzato M.; Indio V.; Urbini M.; Nannini M.; Gatto L.; Schipani A.; Fiorentino M.; Franceschini T.; Ambrosini V.; Di Scioscio V.; Saponara M.; Ianni M.; Concetti S.; Altimari A.; Ardizzoni A.; Astolfi A., Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling, «FRONTIERS IN ONCOLOGY», 2021, 11, Article number: 633543 , pp. 1 - 9 [Scientific article]Open Access

Silvia Malavasi, Diletta Calabrò, Alessandro Bevilacqua, Claudio Ricci, Riccardo Casadei, Davide Campana, Stefano Fanti, Valentina Ambrosini, Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT, in: ECR 2021 – BOOK OF ABSTRACTS, «INSIGHTS INTO IMAGING», 2021, pp. 1 - 1 (atti di: The 33rd European Congress of Radiology (ECR 2021), Vienna (Austria), March 3-7, 2021) [Abstract]

Ambrosini V.; Kunikowska J.; Baudin E.; Bodei L.; Bouvier C.; Capdevila J.; Cremonesi M.; de Herder W.W.; Dromain C.; Falconi M.; Fani M.; Fanti S.; Hicks R.J.; Kabasakal L.; Kaltsas G.; Lewington V.; Minozzi S.; Cinquini M.; Oberg K.; Oyen W.J.G.; O'Toole D.; Pavel M.; Ruszniewski P.; Scarpa A.; Strosberg J.; Sundin A.; Taieb D.; Virgolini I.; Wild D.; Herrmann K.; Yao J., Consensus on molecular imaging and theranostics in neuroendocrine neoplasms, «EUROPEAN JOURNAL OF CANCER», 2021, 146, pp. 56 - 73 [Scientific article]

Mei R.; Allegri V.; Calabro D.; Fanti S.; Ambrosini V., Delayed imaging with oral contrast improves [68Ga]Ga-DOTANOC PET/CT detection of primary duodenal neuroendocrine tumor (NET), «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. 1684 - 1685 [Scientific article]

Kunikowska J.; Ambrosini V.; Herrmann K., EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours—the consensus in a nutshell, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. 1276 - 1277 [Scientific article]

Kunikowska J.; Ambrosini V.; Herrmann K., EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours—the consensus in a nutshell, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. 1276 - 1277 [Scientific article]

Ricco G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Casadei R.; Campana D.; Lamberti G., Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading?, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 10629 , pp. 10629 - 10643 [Scientific article]

Telo S.; Filice A.; Versari A.; Lamberti G.; Campana D.; Calabro D.; Fanti S.; Ambrosini V., Peptide receptor radionuclide therapy for GEP-NET: consolidated knowledge and innovative applications, «CLINICAL AND TRANSLATIONAL IMAGING», 2021, 9, pp. 423 - 438 [Scientific article]

Ingaldi C.; Alberici L.; Ricci C.; Campana D.; Mosconi C.; Ambrosini V.; Lamberti G.; Manuzzi L.; Minni F.; Casadei R., Prophylactic cholecystectomy is not mandatory in patients candidate to the resection for small intestine neuroendocrine neoplasms: a propensity score-matched and cost-minimization analysis, «UPDATES IN SURGERY», 2021, nd, pp. 1 - 8 [Scientific article]

Silvia Malavasi, Diletta Calabrò, Alessandro Bevilacqua, Claudio Ricci, Riccardo Casadei, Davide Campana, Stefano Fanti, Valentina Ambrosini, Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT, in: ECR 2021 – BOOK OF ABSTRACTS, «INSIGHTS INTO IMAGING», 2021, pp. 1 - 1 (atti di: The 33rd European Congress of Radiology (ECR 2021), Vienna (Austria), March 3-7, 2021) [Abstract]

Latest news

At the moment no news are available.